Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • AmelieR
    Junior Member
    • Feb 2017
    • 1

    #1

    Bio-statistics for metatranscriptomic

    Hi everybody,
    I am trying to identified differentially expressed (DE) genes of several bacterial metatranscriptomes.

    To sum up the experimental plan. We have 2 bacterial communities (named E and U) inoculated under 3 different conditions A, B and C (reference condition). I collected both DNA and RNA from time 7 and 9 and also the experiment was performed in duplicate.
    We sequenced RNA (each 24 samples) and metagenome (from pooled of DNA of several samples).

    I assembled and annotated metagenome (141 921 contigs) and use it as reference to map RNA reads with bowtie2.

    I performed DESeq2 analysis on those result and I obtained a large part of DE gene. So I used edgeR to change the normalization way (I had tested TMM, RLE and upperquartile methods) and I obtained around 10 000 DE genes for each comparison of condition (AvsC BvsC and AvsB).

    The problem is that I don't know what is the next step. With a small list of DE gene I would blast the sequence on NCBI and try to identified from which bacterial species, this gene came from and try to identified metabolism pathwas by hand. But with a too large number of DE gene, I don't know how to do.

    Do you think that I have to find another way of normalization to reduce the number of DE gene? Or do you have any idea of software I could use to group those gene by "category" or "class" to go throught the metabolic pathway?

    Thank's for your help.

    Amélie

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...